NASDAQ:FSZ First Trust Switzerland AlphaDEX Fund (FSZ) Price, Holdings, & News $80.82 -1.18 (-1.44%) As of 11:29 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsSEC FilingsTrendsBuy This Stock About First Trust Switzerland AlphaDEX Fund (NASDAQ:FSZ) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get FSZ alerts:Sign Up Key Stats Today's Range$80.82▼$80.8250-Day Range$80.11▼$83.3652-Week Range$75.27▼$86.44Volume340 shsAverage Volume1,650 shsMarket Capitalization$36.37 millionAssets Under Management$36.83 millionDividend Yield2.02%Net Expense Ratio0.80%Aggregate RatingModerate Buy ETF Overview The First Trust Switzerland AlphaDEX Fund (FSZ) is an exchange-traded fund that is based on the NASDAQ AlphaDEX Switzerland index. The fund tracks a tiered, equal-weighted index of 40 Swiss companies selected from the NASDAQ Switzerland Index. It aims to outperform the broader market using a quant-based methodology. FSZ was launched on Feb 14, 2012 and is managed by First Trust. Read More First Trust Switzerland AlphaDEX Fund ExpensesTypeFSZSize and Style ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.80%0.46%0.57%0.54%0.53%Other Expenses0.00%0.50%0.55%0.51%0.55%Total Expense0.80%0.60%0.76%0.73%0.73%Fee Waiver0.00%-0.56%-0.64%-0.50%-0.62%Net Expense0.80%0.48%0.63%0.63%0.60% Receive FSZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for First Trust Switzerland AlphaDEX Fund and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FSZ ETF News HeadlinesSwiss Inflation Holds Steady Ahead of SNB MeetingJune 4, 2026 | wsj.comSwiss Economy Expands AgainMay 18, 2026 | wsj.comElon says “don’t save money.” Is he right?Robert Kiyosaki, author of Rich Dad Poor Dad, says you don't have to wait for Elon Musk's vision of universal basic income. His Patriot Income Plan - funded by 14 partnerships controlling America's critical oil and gas infrastructure - already pays 10% a year with 42 payouts annually. Some investors are already collecting $4,800 a month. One has built income up to $25,000 a month. These partnerships have averaged 20% annual gains since 2020, with no U.S. tax dollars involved. The next payout drops in days.July 22 at 1:00 AM | Freedom Financial (Ad)US tariffs on Swiss goods cut to 15% in deal struck with Trump administrationNovember 14, 2025 | theguardian.comU.S. and Switzerland reach trade deal to lower tariffs to 15%November 14, 2025 | cnbc.comU.S. and Switzerland working on a deal to slash 39% tariffsNovember 11, 2025 | cnbc.comSee More Headlines FSZ ETF - Frequently Asked Questions How have FSZ shares performed this year? First Trust Switzerland AlphaDEX Fund's stock was trading at $80.09 on January 1st, 2026. Since then, FSZ stock has increased by 0.9% and is now trading at $80.82. How do I buy shares of First Trust Switzerland AlphaDEX Fund? Shares of FSZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Fund Details IssuerFirst Trust Fund NameFirst Trust Switzerland AlphaDEX Fund Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:FSZ Inception Date2/14/2012 Fund ManagerDaniel Lindquist, Jon Erickson, David McGarel, Roger Testin, Stan Ueland, Chris Peterson, Erik Russo WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNasdaq AlphaDEX Switzerland Index CategoryBroad Equity FocusSize and Style Development LevelDeveloped Markets RegionEurope Number of Holdings41 Fund Statistics Assets Under Management$36.83 million Average Daily Volume$829.70 Discount/Premium0.15% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorFirst Trust Advisors L.P. CustodianThe Bank of New York Mellon Corporation DistributorFirst Trust Portfolios L.P. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerCitadel Miscellaneous Outstanding Shares450,000Beta0.77 Creation Unit50,000 Creation Fee$800.00 Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report Top 10 FSZ HoldingsSulzer AGHolding Weight: 4.38%Swiss Re AGHolding Weight: 4.36%Flughafen Zürich AGHolding Weight: 4.12%BKW AGHolding Weight: 4.09%ABB LtdHolding Weight: 3.99%VAT Group AGHolding Weight: 3.99%Avolta AGHolding Weight: 3.98%Sandoz Group AGHolding Weight: 3.80%Vontobel Holding AGHolding Weight: 3.63%SFS Group AGHolding Weight: 3.41%Full Holdings DetailsFSZ Sector ExposureFSZ Industry Exposure This page (NASDAQ:FSZ) was last updated on 7/22/2026 by MarketBeat.com Staff. From Our PartnersYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredNNVC: FDA = New Momentum Wave!NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measl...Equiscreen | SponsoredThe smarter SpaceX play most investors will missThere's a classic pattern in every crypto cycle: Bitcoin runs first. Then big altcoins. Then… at the very end…...Crypto 101 Media | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?On July 17th, the House passed the GENIUS Act - and at least one prominent Trump ally is raising alarms. Rep. ...Goldco Direct, LLC | SponsoredElon says “don’t save money.” Is he right?Robert Kiyosaki, author of Rich Dad Poor Dad, says you don't have to wait for Elon Musk's vision of universal ...Freedom Financial | SponsoredTrump’s emergency dollar resetBloomberg research shows the U.S. dollar's share of global reserves has fallen to the lowest level this centur...Porter & Company | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Switzerland AlphaDEX Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Switzerland AlphaDEX Fund With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
